Emphasis on Type (Branded and Generic); Mode of Administration (Injection, Inhalation, and Oral); End-user (Hospitals, Ambulatory Surgical Centers, and Others) and Region/Country
The Global Treprostinil Palmitil Market is expected to grow at a significant rate of around 3.5% during the forecast period. Treprostinil Palmitil, is a generic of Tyvaso and it’s used to treat rare lung issues like pulmonary arterial hypertension and interstitial lung disease. Globally, Treprostinil Palmitil mainly gained prominence due to the increased cases of hypertension and lack of awareness regarding the same among adults. For instance, in July 2023, the Centers for Disease Control and Prevention (CDC) reported only about 1 in 4 adults with hypertension have their hypertension under control. In addition to this, investments in healthcare departments as well as government awareness programs regarding hypertension and, the launch of generics have increased significantly in recent years, which are the key factors that are creating opportunities for the market. For instance, according to the Indian Pharmaceutical Industry Report published in November 2021 by IBEF, India is the world’s top supplier of generic pharmaceuticals. The Indian pharmaceutical industry supplies 40% of the generic demand in the U.S. and 25% of all pharmaceuticals in the U.K.
United Therapeutics Corporation; MannKind Corporation; Insmed Incorporated; Dr. Reddy’s Laboratories Ltd.; Par Pharmaceutical; Sandoz Group AG; Alembic Pharmaceuticals Limited; Teva Pharmaceutical Industries Ltd.; Pharmosa Biopharm Inc.; Liquidia Corporation are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst type, generic category to witness higher CAGR during the forecast period”
Based on type, the market is bifurcated into branded and generic. The generic segment is expected to grow with a high CAGR during the forecast period as it is the cost-effective alternative to branded drugs. They are easily available in maximum regions and are easy on pockets for people in middle to low-income countries. Rising collaborations between pharmaceutical companies are also boosting this segment of the market. For instance, in January 2022, Lupin collaborated with Shenzhen Foncoo Pharmaceutical Co. to introduce high-quality generic and complex generic medicines to patients in India. Thus, the generic category is expected to witness higher CAGR during the forecast period.
“Amongst mode of administration, the oral segment held a significant share in the market in 2022”
Based on the mode of administration, the market is segmented into injection, inhalation, and oral. The oral segment dominated the market in 2022. This segment has been taking over the market because more and more people are taking oral drugs. Tablets are the most popular solid dosage form out of all medication forms because they are effective and easy to consume. People are finding it easier and cheaper to take drugs orally, which is helping this segment grow globally which is a driving factor for this segment. For instance, Dolo has reported making sales of USD 68 million since March 2020, selling more than USD 42 million tablets and USD 0.9 million strips of medicine. Thus, the oral segment held a significant share of the market in the year 2022.
“Amongst end-user, the ambulatory surgical center category to hold a significant share of the market in 2022”
Based on end use, the market is segmented into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers held a significant share of the market in 2022. Ambulatory surgical centers serve as primary healthcare institutions where patients receive an immediate diagnosis, treatment, and ongoing care. They play a pivotal role in the management of patients by providing state-of-the-art medical facilities, specialized expertise, and a multidisciplinary approach to patient care. Rising collaborations and acquisitions are boosting this segment’s growth. For instance, in March 2021, Ascension collaborated with Regent Surgical Health, a developer, owner, and manager of ambulatory surgery centers (ASCs) to operate ambulatory surgery centers across the communities Ascension serves, providing patients with convenient access to high-quality outpatient surgical services. Hence, the ambulatory surgical centers category is expected to witness higher CAGR during the forecast period.
“Amongst regions, North America region held a significant share in the market in 2022”
For a better understanding of the market adoption of treprostinil palmitil, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the global treprostinil palmitil market in the year 2022 due to the increasing pulmonary hypertension cases, and rising number of investments in developing effective therapeutics. For instance, Pulmonary Arterial Hypertension (PTH) is on the rise in the US. In June 2023, the American Lung Association reported that between 500 and 1000 new cases of PTH are diagnosed every year. Government organizations are initiating awareness programs to provide efficient care to patients. Thus, North America held a significant share of the market in the year 2022.
Reasons to buy this report:
Customization Options:
The global treprostinil palmitil market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Key Insights
4. Executive Summary
5. Impact Of Covid-19 On The Treprostinil Palmitil Market
6. Treprostinil Palmitil Market Revenue (usd Bn), 2020-2030f
7. Market Insights By Type
8. Market Insights By Mode Of Administration
9. Market Insights By End-user
10. Market Insights By Region
11. Treprostinil Palmitil Market Dynamics
12. Treprostinil Palmitil Market Opportunities
13. Treprostinil Palmitil Market Trends
14. Demand And Supply-side Analysis
15. Value Chain Analysis
16. Competitive Scenario
17. Company Profiled
18. Disclaimer
Research Methodology for the Treprostinil Palmitil Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global treprostinil palmitil market were the three major steps undertaken to create and analyze the adoption of treprostinil palmitil in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global treprostinil palmitil market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the treprostinil palmitil market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the treprostinil palmitil market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, mode of administration, end-user, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the treprostinil palmitil market. Further, we conducted factor analysis using dependent and independent variables such as type, mode of administration, end-user, and regions of treprostinil palmitil. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the treprostinil palmitil market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global treprostinil palmitil market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 00for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global treprostinil palmitil market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type, mode of administration, end-user, and regions in the global treprostinil palmitil market.
The main objective of the Global Treprostinil Palmitil Market Study
The current & future market trends of the global treprostinil palmitil market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Q1: What is the current market size and growth potential of the treprostinil palmitil market?
Q2: What are the driving factors for the growth of the treprostinil palmitil market?
Q3: Which segment has the largest share of the treprostinil palmitil market by type?
Q4: What are the emerging technologies and trends in the treprostinil palmitil market?
Q5: Which region will dominate the treprostinil palmitil market?
Q6: Who are the key players operating in the treprostinil palmitil market?
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
